poor people's diseases

Here's a great NYT article which discusses some of the challenges we face trying to treat "poor people's diseases."

It discusses the difficulties of funding research for cures of diseases that don't kill people in rich countries, like malaria and TB.

(It does not discuss the ways that our five collective bouts with malaria this year may have impacted the market for artemisinin-based combination therapy in Rwanda.)